Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22405
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRigau, Marc-
dc.contributor.authorOstrouska, Simone-
dc.contributor.authorFulford, Thomas S-
dc.contributor.authorJohnson, Darryl N-
dc.contributor.authorWoods, Katherine-
dc.contributor.authorRuan, Zheng-
dc.contributor.authorMcWilliam, Hamish E G-
dc.contributor.authorHudson, Christopher-
dc.contributor.authorTutuka, Candani-
dc.contributor.authorWheatley, Adam K-
dc.contributor.authorKent, Stephen J-
dc.contributor.authorVilladangos, Jose A-
dc.contributor.authorPal, Bhupinder-
dc.contributor.authorKurts, Christian-
dc.contributor.authorSimmonds, Jason-
dc.contributor.authorPelzing, Matthias-
dc.contributor.authorNash, Andrew D-
dc.contributor.authorHammet, Andrew-
dc.contributor.authorVerhagen, Anne M-
dc.contributor.authorVairo, Gino-
dc.contributor.authorMaraskovsky, Eugene-
dc.contributor.authorPanousis, Con-
dc.contributor.authorGherardin, Nicholas A-
dc.contributor.authorCebon, Jonathan S-
dc.contributor.authorGodfrey, Dale I-
dc.contributor.authorBehren, Andreas-
dc.contributor.authorUldrich, Adam P-
dc.date2020-01-09-
dc.date.accessioned2020-01-13T04:06:12Z-
dc.date.available2020-01-13T04:06:12Z-
dc.date.issued2020-02-07-
dc.identifier.citationScience 2020; 367(6478): eaay5516en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/22405-
dc.description.abstractGamma delta (γδ) T cells are essential to protective immunity. In humans, most γδ T cells express Vγ9Vδ2+ T cell receptors (TCRs) that respond to phosphoantigens (pAg) produced by cellular pathogens and overexpressed by cancers. However, the molecular targets recognized by these γδTCRs are unknown. Here, we identify butyrophilin 2A1 (BTN2A1) as a key ligand that binds to the Vγ9+ TCR γ-chain. BTN2A1 associates with another butyrophilin, BTN3A1, which act together to initiate responses to pAg. Furthermore, binding of a second ligand, possibly BTN3A1, to a separate TCR domain incorporating Vδ2 is also required. This unique mode of Ag-dependent T cell activation advances our understanding of diseases involving pAg recognition and creates opportunities for the development of γδ T cell-based immunotherapies.en
dc.language.isoeng-
dc.titleButyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.en
dc.typeJournal Articleen
dc.identifier.journaltitleScienceen
dc.identifier.affiliationUniversity of Bonn, Bonn, Germanyen
dc.identifier.affiliationDepartment of Microbiology & Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australiaen
dc.identifier.affiliationLudwig Institute for Cancer Research, Melbourne -Austin Branch Victoria 3084, Australiaen
dc.identifier.affiliationAustralian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australiaen
dc.identifier.affiliationDepartment of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australiaen
dc.identifier.affiliationAustralian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australiaen
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Melbourne, Victoria 3010, Australiaen
dc.identifier.affiliationCSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australiaen
dc.identifier.affiliationUniversity of Bonn, Bonn, Germanyen
dc.identifier.doi10.1126/science.aay5516en
dc.type.contentTexten
dc.identifier.orcid0000-0001-5978-1073en
dc.identifier.orcid0000-0001-7582-3990en
dc.identifier.orcid0000-0003-3474-3104en
dc.identifier.orcid0000-0003-3479-3419en
dc.identifier.orcid0000-0002-1420-6988en
dc.identifier.orcid0000-0003-3344-4102en
dc.identifier.orcid0000-0002-5593-9387en
dc.identifier.orcid0000-0002-8539-4891en
dc.identifier.orcid0000-0001-6771-8891en
dc.identifier.orcid0000-0002-6620-2401en
dc.identifier.orcid0000-0003-1947-8701en
dc.identifier.orcid0000-0003-1330-7303en
dc.identifier.orcid0000-0002-6945-8672en
dc.identifier.orcid0000-0003-3690-6253en
dc.identifier.orcid0000-0003-4690-2571en
dc.identifier.orcid0000-0002-3898-950Xen
dc.identifier.orcid0000-0002-3009-5472en
dc.identifier.orcid0000-0001-5329-280Xen
dc.identifier.orcid0000-0002-6350-5976en
dc.identifier.pubmedid31919129-
dc.type.austinJournal Article-
local.name.researcherCebon, Jonathan S
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Jan 21, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.